Regadenoson

In the US, Regadenoson (regadenoson systemic) is a member of the drug class cardiac stressing agents and is used to treat Diagnosis and Investigation and Radionuclide Myocardial Perfusion Study.

US matches:

• Regadenoson


• Regadenoson Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C01EB21

CAS registry number (Chemical Abstracts Service)

0875148-45-1

Chemical Formula

C15-H18-N8-O5·H2O

Molecular Weight

408

Therapeutic Categories

Coronary vasodilator

Adenosine receptor antagonist A₂A

Chemical Names

(1-(9-(3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6-aminopurin-2-yl)pyrazol-4-yl)-N-methylcarboxamide, monohydrate

(2R,3R,4S,5R)-1-[6-Amino-9-(3,4-dihydroxy-5-hydroxymethyltetrahydrofuran-2-yl)-9H-purin-2-yl]-1H-pyrazol-4-carbonsäuremethylamid, monohydrat (IUPAC)

1-(6-amino-9-beta-D-ribofuranosyl-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide, monohydrate (USAN)

1-[6-Amino-9-(b-D-ribofuranosyl)-9H-purin-2-yl]-N-methyl-1H-pyrazole-4-carboxamide, monohydrate (BAN)

Adenosine, 2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]-, monohydrate (USAN)

Foreign Names

• Regadenosonum (Latin)
• Regadenoson (German)
• Régadénoson (French)
• Regadenosón (Spanish)

Generic Names

• Regadenoson (OS: BAN, USAN)
• CVT-3146 (IS: CV Therapeutics)
• UNII-2XLN4Y044H (IS)

Brand Name

• Lexiscan
  Astellas, United States

International Drug Name Search

Glossary

BAN	British Approved Name
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.